ArticleJournal of hematology & oncology2023

Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression.

Ziqiang Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.